Heliox Market Size, Share, Growth, and Industry Analysis, By Type (79/21(Helium/Oxygen mixtures), 70/30(Helium/Oxygen mixtures), 60/40(Helium/Oxygen mixtures) & 90/10(Helium/Oxygen mixtures)), By Application (Medical Uses & Diving Uses), and Regional Forecast to 2033

HELIOX MARKET OVERVIEW

Heliox Market Size was estimated at USD 29402.79 million in 2024 and it is expected to grow from USD 30034.95 million in 2025 to USD 31340.34 million by 2033. The Market CAGR (growth rate) is expected to be around 2.15% during the forecast period (2025 - 2033).

The Heliox market, based on a therapeutic gas mix of helium and oxygen, is experiencing demand due to respiratory treatment and critical care, which, because of helium’s low density, simplifies breathing through constricted air passages and aids lung therapies. Their sale and use in healthcare facilities as well as the improvements of medical gases are adding to the demand. Similarly, the telemedicine market is growing at the same pace due to enhancements in remote healthcare technology, the need for virtual consultations, coupled with the availability of improved digital health solutions empowering patient treatment in various population groups.

• 

  Request a Free Sample to learn more about this report

GLOBAL CRISES IMPACTING HELIOX MARKET - COVID-19 IMPACT

"Heliox Industry Had a Positive Effect Due to Growing Necessity during COVID-19 Pandemic"

The Global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

The Global heliox market celebrated a major upturn during the course of the COVID-19 pandemic owing to the increased need for respiratory support systems in intensive care areas. The gas mixture, which was used to facilitate breathing in other severe lung diseases, found its application in managing the complications arising from COVID and became critical in intensive care units across the world. However, improved awareness of the respiratory therapies applied the Heliox market to become a critical tool during the pandemic mode of operation and beyond.

LATEST TREND

"Technological improvements delivery systems drive market growth"

The Heliox market has recently witnessed technological improvements in portable Heliox delivery systems, attributed to high demand due to the possibility of increasing usage in emergency and remote practices. Other trends include advanced methods of storing gas and the tendency for greater interaction with respiratory monitoring that increases treatment accuracy. Heliox has again been placed at a vantage position in emergency respiratory management due to variables such as the portable devices, specifically, that are being issued in pre-hospital care settings.

• 

  Request a Free Sample to learn more about this report

HELIOX MARKET SEGMENTATION

By Type

Based on Type, the global market can be categorized into 79/21(Helium/Oxygen mixtures), 70/30(Helium/Oxygen mixtures), 60/40(Helium/Oxygen mixtures) & 90/10(Helium/Oxygen mixtures)

• 79/21 – Helium/Oxygen Mixture That’s why the 79/21 helium oxygen mixture is most preferred for severe asthma and COPD patients because of the helium oxygen combination. Its mixture helps to lessen the airway resistance and hence make the patient comfortable, especially during respiratory distress. They have reached across most of the institutions for emergencies and intensive care.

• 70/30 (helium/oxygen mixtures) Therapeutic applications of the 70/30 helium-oxygen blend include circumstances in which reduced oxygen levels are desirable, as in hyperbaric medicine. This combination provides better oxygen exchange yet preserves low resistance of the respiratory tract, which is effective for selected lung diseases. Utilization is increasing in some more specific healthcare centers, primarily in Europe and North America.

• (Seven members) 60/40 (helium/oxygen mixtures) The 60/40 helium-oxygen mixture will be mostly used in methods such as bronchial challenges and some diagnostic procedures. This mixture enhances diffusion, thereby making it suitable for use in pulmonary function tests. It is used and demanded more often due to the search for better ways to address respiratory health challenges.

• 90/10 (helium/oxygen mixtures) It is used where there is a need to supplement high levels of oxygen with the helium used in a ratio of 90%:10% in order to enhance efficiency in breathing. It is especially effective when used in this combination in the treatment of acute respiratory distress syndrome (ARDS) and other serious respiratory compromises. Its use is gradually increasing because it has several benefits as a fast solution to respiratory illnesses in healthcare facilities.

By Application

Based on Application, the global market can be categorized into Medical Uses & Diving Uses

• Medical Uses Inhalation is used commonly in the medical field and especially for respiratory disorders, including asthma, COPD, and the acute respiratory distress syndrome. Due to its special features, it decreases airway resistance, helps to exchange gases, and is used in emergency and intensive care departments. Its use as a therapeutic molecule is quickly gaining popularity, thus enlarging its demand in hospitals and other health facilities.

• Diving Uses In diving applications, Heliox is used to minimize nitrogen narcosis and other decompression illnesses that relate to deep sea diving. Helium and oxygen in combination are used so that divers can traverse deeper parts without bottom pressure affecting the body. It is widely preferred by the commercial divers and research teams underwater since it increases safety and working effectiveness.

MARKET DYNAMICS

Market dynamics include driving and restraining factors, opportunities and challenges stating the market conditions.

Driving Factors

"Rising respiratory diseases drive market growth"

The prime driver of the demand for better respiratory solutions such as Heliox is the increasing solution of diseases like chronic obstructive pulmonary disease and asthma. Heliox winds its way through obstructed airways, and this makes it popular in the treatment of advanced respiratory ailments.

"Advancements in systems enhance market growth opportunities globally"

Recent advancements in portable gas delivery systems added the refinement of Heliox delivery systems as supportive in respiratory care. These advancements have expanded the uses of Heliox in non-emergency and critical care settings, thus improving Global Heliox market growth.

Restraining Factor

"High production costs hinder market growth and adoption in hospitals"

Market access challenge that is closely related to Heliox production as well as storage costs, which prevents more hospitals from purchasing it. This financial barrier hinders the laying of fiber optic cables, thus limiting their adoption in the market, especially in commodity-sensitive markets.

Opportunity

"Healthcare market growth increases demand for respiratory therapies"

One more advantageous prospect of the Heliox market’s development is its enhancement in the reasonably growing healthcare markets where progressive respiratory care tools are getting introduced. With increasing healthcare complexities in such regions, there is likely to be increased specificity for therapies such as Heliox; hence, the physical market for this product is available and can be extended.

Challenge

"Lack of knowledge hinders market growth and Heliox implementation globally"

One of the main obstacles in the Heliox market is the lack of knowledge of specialists in the field of treatment with Heliox and its correct application. Moreover, Heliox is complex in its usage, which means that the lack of qualified staff might become an issue for the programs’ implementation, especially in underdeveloped or developing countries.

• 

  Request a Free Sample to learn more about this report

HELIOX MARKET REGIONAL INSIGHTS

North America

North America is the largest consumer in the Heliox market due to factors such as better infrastructure in healthcare, high utilization of respiratory therapy, and better expenditure in the technology for critical care. The United States Heliox Market, more specifically, is driving growth due to growing research and development funding in respiratory support, making the US a primary market driver for the region.

Europe

Europe holds a larger market share in the global Heliox market due to the most advanced healthcare infrastructure and increasing consumption for respiratory therapy in diseases such as COPD and asthma. Thus, countries like Germany and the UK are identifying the increasing potential of medical gas solutions and embracing the market with investment. Also, the backup from the authorities for steep innovative respiratory therapies is driving Heliox penetration throughout the region.

Asia

Asia is gradually coming up as a force to reckon with within the Heliox market due to the rising incidence of respiratory ailments as well as poor air quality prevalent in countries such as China and India. Awareness of developments in healthcare and improvements in primary care are factors driving its uptake by organizations. On this note, measures that have been taken by governments across the region to enhance critical care facilities are in turn fostering market growth for Heliox.

KEY INDUSTRY PLAYERS

"Industry players drive market growth through partnerships and increased awareness"

Industry players are determined the Heliox market moves through partnerships and integration of new delivery systems and an upsurge in research on Heliox. A trend related to the Heliox solutions is the increase of efficiency and portability to make patients have easier access. Furthermore, these players are initiating awareness campaigns to create health care providers’ awareness about the Heliox and encourage them to use it in different health care sectors.

List of Top Heliox Companies

• TAIYO NIPPON SANSO (Japan)
• Praxair (U.S)
• Air Products and Chemicals, Inc (U.S)
• Air Liquide (France)
• Messer Group (Germany)

KEY INDUSTRY DEVELOPMENT

April 2024, Air Liquide, which provides medical gases, recently unveiled its new Heliox delivery system for EMS and hospitals. This new development in Heliox therapy improves the transportability and effectiveness of the therapy with regard to patient care in respiratory distress episodes that are critical, making a positive impact on the growth of the Heliox market.

REPORT COVERAGE

The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential Applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.

This research report examines the segmentation of the market by using both quantitative and qualitative methods to provide a thorough analysis that also evaluates the influence of strategic and financial perspectives on the market. Additionally, the report's regional assessments consider the dominant supply and demand forces that impact market growth. The competitive landscape is detailed meticulously, including shares of significant market competitors. The report incorporates unconventional research techniques, methodologies and key strategies tailored for the anticipated frame of time. Overall, it offers valuable and comprehensive insights into the market dynamics professionally and understandably.